Cell growth is promoted by mitogens and survival factors, which activate intracellular signalling pathways to control cell cycle progression and cellular integrity. Proliferation signals are transmitted through Ras and Rho family small G-proteins coupled to mitogen-activated protein kinase (MAPK) cascades, while survival signals are propagated by lipid-dependent kinases such as phosphatidylinositide 3-kinases (PI3Ks) and protein kinase B (Akt/PKB). Recently, signal transducer and activator of transcription (STAT) proteins were identified as positive regulators of proliferation in a variety of cell types. Persistent activation of these pathways is associated with tumour cell growth, whereas their inhibition can halt proliferation and precipitate apoptotic cell death. The human pathogen Pseudomonas aeruginosa uses quorum-sensing signal molecules (QSSMs) to regulate virulence gene expression. QSSMs also suppress host immune responses although the mechanism of suppression is unknown. Here, we demonstrate that the QSSM N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL) from P. aeruginosa blocks proliferation and induces apoptosis in human BC cell lines. Analyses of signalling events reveal that OdDHL has little or no effect on MAPK cascades, partially inhibits the Akt/PKB pathway and ablates STAT3 activity. Pharmacological inhibition of each pathway independently indicates that STAT3 activity is critical for BC cell proliferation and survival, while a constitutively active STAT3 confers resistance to OdDHL. These results support the notion of OdDHL as a bioactive molecule in eukaryotic systems and a paradigm for a novel class of antiproliferative compounds.
Introduction
Survival and proliferation of mammalian cells is regulated by a complex array of mitogenic cytokines and growth factors. Proliferative signals from activated growth factor receptors converge on Ras and Rho family small G-proteins, which undergo conformational changes induced by GTP-binding to allow interactions with downstream effectors (Pruitt and Der, 2001) . Central to proliferation is the activation of the mitogen-activated protein kinase (MAPK) cascade leading to nuclear translocation of active extracellular signalregulated kinases (ERKs) and stimulation of immediate-early genes (IEGs) whose products initiate the cell cycle (Ko¨lch, 2000) . A second Ras effector pathway, which is also stimulated directly by growth factor receptors, involves phosphatidylinositide 3-kinases (PI3Ks), which activate a lipid-dependent kinase cascade that transmits prosurvival and antiapoptotic signals to ward off programmed cell death (Vanhaesebrook and Alessi, 2000) .
Signal transducer and activator of transcription (STAT) proteins are also implicated in cell growth control. Activated cytokine receptors provide scaffolds upon which STATs are phosphorylated by Janus Kinases (JAKs) (Seidel et al., 2000) , whereupon STATs translocate to the nucleus and upregulate the expression of target genes, including those for numerous cytokines (Kotenko and Pestka, 2000; Reddy et al., 2000) . STAT3 plays a role in driving proliferation and counteracting differentiation signals (Bowman et al., 2000; Bromberg and Darnell, 2000) , and a STAT3 mutant that dimerizes in the absence of tyrosine phosphorylation is constitutively active and functions as an oncogene (Bromberg et al., 1999) . Moreover, the proliferation of a range of tumour-derived cells, notably of breast carcinoma (BC) origin, has been shown to depend on the constitutive activity of STAT3 (Burke et al., 2001; Garcia et al., 2001; Li and Shaw, 2002) .
The intimate associations between pathogen and host make it likely that the former have evolved subtle and selective strategies to subvert the regulatory systems of the latter. Thus it has been shown that N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL), a quorumsensing signal molecule (QSSM) from P. aeruginosa (Winson et al., 1995; Pesci et al., 1997) , can suppress immune responses of the type commonly associated with antibacterial immunity and the development of autoimmune disease (Telford et al., 1998) . Other data suggest that these molecules may also stimulate proinflammatory activity (Smith et al., 2002) . However, the underlying mechanisms are obscure and a molecular target for OdDHL in eukaryotic cells remains to be identified.
Given the ability of N-acylhomoserine lactones (AHLs) to modulate immune function (Telford et al., 1998) , we explored their possible influence on other aspects of eukaryotic cell control, in particular proliferation. Here, we report that OdDHL induces apoptotic cell death in several BC cell lines. To home in on the mechanism of OdDHL action, we examined its effects on several signal cascades. MAPKs were largely unaffected by OdDHL. However, the Akt/PKB pathway was partially inhibited and STAT3 phosphorylation and DNA binding were abolished. Pharmacological inhibition of each pathway independently confirmed that BC cell apoptosis correlated with the inhibition of STAT3 activity. Finally, overexpression of a constitutively active STAT3 protein was found to confer resistance to OdDHL-induced apoptosis. These findings confirm OdDHL as a bioactive molecule in eukaryotic systems and identify the JAK/STAT pathway as one likely target for its actions. In addition, they unveil OdDHL as a paradigm for a novel class of antiproliferative compounds.
Results

Effects of AHLs on BC cell proliferation
Several BC cell lines were treated with AHLs and their proliferation was monitored. As shown in Figure 1a , BR293 cells treated with vehicle (DMSO) or N-(3-oxohexanoyl)-L-homoserine lactone (OHHL), an OdDHL analogue that lacks immune-modulatory activity, reached confluence in 48 h whereas those exposed to OdDHL grew poorly. Indeed, 50-100 mM OdDHL markedly inhibited the proliferation of three tumorigenic BC cell lines by 70-80% (Figure 1b ). By comparison, its effect on a nontumorigenic breast epithelial cell line (MCF-10F) was slight.
OdDHL induces apoptosis in proliferating BC cells
The low survival of BC cells in the presence of OdDHL suggested that they might be undergoing apoptosis. Significantly, in flow cytometry experiments, we observed that OdDHL treatment (100 mM for 6 h) led to a 6-8-fold increase in annexin V binding in MCF-7 and MDA-MB-468 cells, consistent with early apoptotic cells, but less than a two-fold increase in MCF-10F cells (see Supplementary data). However, as this assay proved to be rather ineffective for these adherent cells, we also examined the integrity of poly-ADP-ribose polymerase (PARP), an established caspase target. Although BR293 cells express low levels of PARP, the characteristic cleavage fragment was detected in cells treated with 100 mM OdDHL (Figure 2a Another hallmark of apoptosis is DNA fragmentation. As shown in Figure 2b , treatment of MDA-MB-468 and BR293 cells with OdDHL for 18 h also results in DNA laddering (lanes 3 and 5). In MCF-7 cells DNA laddering is known to be an unreliable indicator of (Gooch and Yee, 1999) and in our cells it was only weakly apparent (lane 9). As anticipated, DNA laddering was not detected in OdDHL-treated MCF-10F cells (lane 7). Together, these results indicate that treatment of proliferating BC cells with OdDHL leads to their apoptotic demise.
Influence of odDHL on MAPK cascades
The effects of OdDHL on BC cells prompted us to monitor changes in intracellular proliferation and survival signals. One consequence of mitogenic stimulation is the activation of MAPKs, reflected by the phosphorylation of ERKs and, in some cases, cJun Nterminal kinases/stress-activated protein kinases (JNK/ SAPKs) and p38
MAPK (Robinson and Cobb, 1997; Ko¨lch, 2000) .
Pretreatment of BR293 cells for 30 min with increasing concentrations of OdDHL or with 100 mM OHHL had no effect on ERK phosphorylation in response to TPA (Figure 3a ) or serum (data not shown). In contrast, a modest but reproducible inhibition of JNK/SAPK ( Figure 3b ) and p38 MAPK phosphorylation (Figure 3c ) was seen at 100 mM OdDHL, but not at 100 mM OHHL, in cells treated with anisomycin, an established stress agonist. However, it seemed unlikely that this inhibition of stress-activated MAPKs causes the antiproliferative effects of OdDHL. In MDA-MB-468 and MCF-7 cells, an elevated background level of ERK activity was observed that could be partially reduced by OdDHL treatment whereas JNK/SAPK and p38 MAPK phosphorylation in response to anisomycin was refractory to OdDHL treatment (Figure 3d -f and data not shown). In summary, the marginal influence of OdDHL on MAPK activity does not correlate with its effect on BC cell proliferation and survival.
Effect of AHLs on PI3K signalling
A key event in cell survival is the recruitment of Akt/PKB to phosphatidylinositol 3,4,5-trisphosphate (PIP3) at the cell membrane where it is phosphorylated by the phospholipid-dependent kinase PDK1 (Vanhaesebrook and Alessi, 2000) . To detect changes in survival signals in response to AHLs, we monitored Akt/PKB phosphorylation. Pretreatment of BR293 cells for 30 min with concentrations of OdDHL up to 100 mM revealed a partial inhibition of Akt/PKB phosphorylation ( Figure 4 , upper panels, lane 4). Complete inhibition was observed in cells treated with Wortmannin, a specific inhibitor of PI3 K (lane 3). Identical experiments were performed with MDA-MB-468 and MCF-7 cells, with similar results (lower panels). Thus, at concentrations that block BC cell proliferation and induce apoptosis, OdDHL causes a partial inhibition of PI3 K signalling that could contribute to their demise.
Effect of AHLs on STAT3 activity
As STAT3 is implicated in proliferation, the effects of OdDHL on STAT3 activity in BC cells were also tested. OdDHL completely inhibited serum-induced STAT3 tyrosine phosphorylation in BR293 and MDA-MB-468 cells at 100 mM, whereas OHHL had only a slight effect ( Figure 5a and b, compare lanes 6 and 7). STAT3 phosphorylation was also inhibited by OdDHL at 75 mM and in MCF-7 cells (Supplementary data and data not shown). STAT3 phosphorylation is not detected in serum-stimulated MCF-10F cells (Li and Shaw, 2002 and data not shown). The effects of AHLs on STAT3 were more pronounced when nuclear extracts were prepared and assayed with a high affinity STAT1/ STAT3 binding site (M67SIE) (Wagner et al., 1990) . OdDHL inhibited DNA binding by STAT3 at 50 mM ( Figure 5c and d, lanes 9 and 10), while OHHL at 100 mM had only a marginal effect (lanes 13 and 14). STAT3-containing complexes were distinguished with a STAT3-specific antibody. The lower IC 50 for DNAbinding suggests that the negative impact of OdDHL on STAT3 phosphorylation may be an indirect consequence of OdDHL acting on a subsequent event in the activation mechanism. 
Susceptibility of BC cell survival to specific pathway inhibition
Although OdDHL affected the STAT3 activation pathway most severely, its influence on other signalling pathways implicated in cell growth prompted us to assess the relative importance of each for BC cell survival. Thus MDA-MB-468, BR293 and MCF-10F cell proliferation over 48 h was compared in the presence of pathway-specific antagonists. As shown in Figure 6a , the p38 MAPK inhibitor SB203580 had no effect on BR293 cell proliferation, while the MAPK/ERK Kinase (MEK) inhibitor PD98059 and Wortmannin both reduced proliferation by 20%. In contrast, AG490, a JAK inhibitor that blocks STAT3 activation (Garcia et al., 2001; Li and Shaw, 2002) , reduced proliferation by 80%. Similarly, in MDA-MB-468 cells AG490 was twice as effective as the other inhibitors, reducing proliferation by 70%. None of the inhibitors reduced the level of MCF-10F cell growth by more than 30%.
Similar results were obtained when PARP cleavage was monitored. As shown in Figure 6b , only AG490 induced PARP cleavage in MCF-7 and MDA-MB-468 cells. This comparison demonstrates that the proapoptotic effects of OdDHL correlate with the blockade of STAT3 activity, implying that the primary target of OdDHL is the JAK/STAT pathway.
Resistance to OdDHL-induced apoptosis conferred by constitutively active STAT3
We, and others, have previously shown that dominant inhibitory versions of STAT3 inhibit proliferation of several BC cell lines (Garcia et al., 2001; Li and Shaw, 2002) . We therefore reasoned that if inhibition of STAT3 was the key role of OdDHL, a constitutively active STAT3 protein (STAT3-C; (Bromberg et al., 1999) , which has been shown to protect fibroblasts from UV-induced apoptosis (Shen et al., 2001) , should confer protection on cells in which it was expressed. Whereas OdDHL treatment inhibited the proliferation of MCF-7 cells transfected with a control vector by 80%, proliferation of cells expressing STAT3-C was reduced by only 36% (Figure 7a ). We also looked at the proportions of apoptotic cells under these conditions. As shown in Figure 7b , 64% of control cells were Annexin V positive after OdDHL-treatment, but this was reduced to 19.3% in cells expressing STAT3-C. Again these results are consistent with the inhibition of STAT3 being the key antiproliferative action of OdDHL.
Discussion
Based on the premise that pathogens gain advantage by subverting regulatory events in host cells, we explored the possibility that the QSSMs of P. aeruginosa can modulate cell proliferation and survival signalling in human tumour cells. We found that OdDHL, but not its short chain analogue OHHL, is able to induce apoptosis in proliferating BC cells, which it achieves primarily by the downregulation of STAT3 activity.
Effects of OdDHL on growth signals in BC cells
As OdDHL had been observed to block proliferation of murine T cells (Telford et al., 1998) , the apoptotic death of BC cells was not entirely unexpected. Moreover, our examination of the effect of OdDHL on STAT3 activation, as well as on established proliferation and survival pathways, was prompted by demonstrations that STAT3 activity is critical for BC cell proliferation, and the overt role of JAK/STAT signalling in T and B cell homeostasis. Furthermore, a role for JNK/SAPK signalling in cSrc-induced STAT3 activity has been reported The inability of OdDHL to block mitogen-induced ERK phosphorylation in these BC cell lines, while surprising, demonstrates that susceptible cells do not capitulate to a pleiotropic effect of OdDHL on signalling events. However, the slight reduction in JNK/SAPK phosphorylation seen upon dual administration of anisomycin and OdDHL may contribute to STAT3 downregulation. At the same time, it indicates that BC cells do not mount a stress response to OdDHL. Partial inhibition of Akt/PKB phosphorylation was observed in response to OdDHL. Serine 473 lies in the C-terminal hydrophobic motif of Akt/PKB and its phosphorylation by PDK1 is an essential step in the PI3 K signalling pathway (Vanhaesebrook and Alessi, 2000) . As PDK1 is constitutively active, regulation of Akt/PKB phosphorylation depends almost exclusively on accumulation of PIP3 at the cell membrane, which in turn is highly labile. The efficacy with which OdDHL induces apoptosis and the relatively slow loss of Akt/ PKB phosphorylation therefore indicate that the partial inhibition of PI3 K signalling is likely to be an indirect consequence of OdDHL action. This inference is also supported by the fact that direct inhibition of the PI3 K pathway by Wortmannin is relatively ineffective at blocking proliferation or inducing apoptosis, as assessed by PARP cleavage.
The strongest correlation was seen between the inhibition of STAT3 and the reduction in BC cell proliferation. OdDHL concentrations that induced apoptosis ablated STAT3 activity. Notably, the breast epithelial MCF-10F cell line, which was insensitive to OdDHL shows low levels of STAT3 activity (Simon et al., 2000; Li and Shaw, 2002) . A small increase in STAT3 phosphorylation at 50 mM OdDHL was observed consistently in BR293 cells, as was an increase in DNA binding by STAT1 and STAT3 at 20 mM. In MDA-MB-468 cells, similar increases were also observed. One possible explanation is that OdDHL may have more than one cellular target. Alternatively, the direct target of OdDHL may have opposing influences on two signal pathways converging on STAT3. Given that serum is a mixed agonist, it is conceivable that multiple signals contribute to the net stimulation of STAT3 and BC-cell proliferation, and further studies on the effects of OdDHL on JAK/STAT signalling are underway.
Several models for the activation of STATs have been proposed, a common aspect being their recruitment to phosphorylated receptor chains from a pool of latent cytoplasmic monomers. However, recent reports indicate that inactive STATs may exist in distinct fractions, not only as cytoplasmic monomers or dimers but also in multiprotein complexes (Lackmann et al., 1998; Ndubuisi et al., 1999; Haan et al., 2000) . Following growth factor stimulation, nuclear translocation of STAT3 has been shown to require receptor-mediated endocytosis (Bild et al., 2002) and separate nuclear import pathways have been identified for STAT1 monomers and dimers that are predicted to be conserved among STAT proteins (Meyer et al., 2002) . As STAT3 activation in response to EGF stimulation is unimpaired (LL and PES, unpublished observations), OdDHL is unlikely to influence these aspects of STAT regulation.
The role of JAKs extends beyond STAT activation as residues phosphorylated by JAK2 on ErbB2 and gp130 have been shown to serve as docking sites for Grb2 and SHP2, respectively. Both proteins, either directly or through Gab1, transmit signals to the ERK cascade (Hirano et al., 2000; Yamauchi et al., 2000) . Activation of this hypothetical pathway would be consistent with IEG expression and autocrine secretion, which are implicated as downstream events in the pathway blocked by OdDHL (Li and Shaw, 2002 and unpublished data) . However, OdDHL had little effect on ERK activation and preliminary data suggest that OdDHL does not interfere with JAK2 phosphorylation in serumstimulated cells (LL and PES, unpublished data), ruling out JAK2 as the molecular target of OdDHL.
Role of STAT3 in BC cell proliferation
Much data have accumulated to implicate STAT3 as a positive regulator of proliferation in a range of tumour tissues. Evidence includes the effects of dominantinhibitory STAT3 mutants, which reduce proliferation of several tumour cell types, counteract transformation by several oncogenes and exert a negative-selection on the establishment of stable cell lines in which they are expressed (reviewed in Turkson and Jove, 2000) . STAT3 is involved in the expression of several proteins that participate in cell cycle control. It mediates the induction of c-myc in response to growth factors, including IL-6, and oncogenes including v-src and v-abl (reviewed in Hirano et al., 2000) , which would contribute to G 1 -S progression. In addition, Pim1 has been identified as a STAT3-responsive gene. Pim1 encodes a serine/threonine kinase that phosphorylates and activates Cdc25A, a major regulator of cyclin-dependent kinases. In the absence of STAT3 activity constitutive expression of both Pim1 and cMyc was shown to be required for cell cycle progression (Mochizuki et al., 1999; Shirogane et al., 1999) . Thus, STAT3 acts as a positive regulator of the cell cycle.
STAT3 also influences the balance between survival and apoptotic signals. Several lines of evidence indicate that prosurvival Bcl-family members are upregulated by STAT3. For example, the high level of Bcl XL expressed in the Fas-resistant myeloma cell line U266 is reduced upon STAT3 inactivation, whereupon the cells undergo apoptosis (Catlett-Falcone et al., 1999) . More recently, STAT3 has been implicated in the expression of Mcl-1, another Bcl-2 prosurvival family member, and members of the inhibitors of apoptosis (IAP) family in human macrophages and neutrophils, respectively (Hasegawa et al., 2003; Liu et al., 2003) . While loss of Mcl-1 is associated with cytochrome c release from mitochondria and the activation of procaspase 9, IAPs are reported to interfere with the activation of procaspases 8 and 9 (Deveraux et al., 1998) . Thus, depending on cell type, constitutive STAT3 activation may serve to counteract both extrinsic and intrinsic mechanisms of apoptotic demise. Although our findings do not distinguish between these possibilities, they further highlight the role of STAT3 in antiapoptotic signalling. Hirano et al., 2000; Smithgall et al., 2000) . In addition, STAT proteins are constitutively active in many leukaemias (reviewed in Lin et al., 2000) . Although pathogens might benefit from strategies that reduce T-or B-cell numbers, a more effective mechanism would be to subvert T-and B-cell signalling. Indeed, OdDHL has been shown to downregulate TNFa and IL-12 production by macrophages and to enhance IgE production from IL-4-stimulated peripheral blood mononuclear cells (PBMCs) (Telford et al., 1998) . It is conceivable that these responses could result from the modulation of STAT activity.
Materials and methods
Cell culture and extract preparation BC-cell lines (BR293, MCF-7 and MDA-MB-468) and MCF-10F cells were cultured as described previously (Li and Shaw, 2002) . For EMSAs, cells were seeded in 10 cm dishes and cultured until confluent. Thereafter, the cells were maintained in serumfree medium overnight before application of appropriate stimuli. Nuclear extracts were prepared as described previously (Li and Shaw, 2002) in high salt hypertonic buffer (20 mM HEPES pH7.9, 420 mM NaCl, 20% glycerol, 1 mM EDTA, 1 mM EGTA, 20 mM NaF, 1 mM Na 3 VO 4 , 1 mM Na 4 P 2 O 7 , 2 mM benzamidine, 0.5 mM PMSF, 1 mM DTT and 1 mg/ml/ À1 each of leupeptin, aprotinin and pepstatin).
For immunoblotting experiments, lysates were prepared in TBSN buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40) supplemented with protease inhibitors (1 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , 10 mM NaF, 5 mM EGTA, 10 mM benzamidine, 0.2 mM PMSF and 1 mg/ml each of leupeptin, aprotinin and pepstatin). Lysates were cleared by centrifugation at 16 000 g for 10 min and used directly for immunoprecipitations or stored at À201C for further use.
Plasmids and oligonucleotides
The expression vectors for wild-type STAT3 was a gift from Drs Curt Horvath (Mount Sinai, USA) and James Darnell (Rockefeller, USA). The luciferase reporter pM67/SIE2-luc contains two copies of the M67SIE upstream of the adenovirus 2 E4 basal promoter.
The oligonucleotides used to generate the M67SIE EMSA probe derived from the vSis-inducible element (SIE) of the human c-fos promoter are:
Upper: 5 0 -CTAGCATTTCCCGTAAAT Lower: 5 0 -CTAGATTTACGGGAAATG
Antibodies
The anti-STAT3 monoclonal antibody was from Transduction Laboratories; the antiphospho-STAT3 monoclonal antibody was from Upstate Biotechnology; the rabbit polyclonal anti-STAT3, anti-p38 and anti-JNK antisera were made in our laboratory; the antiphospho-JNK antibody was from Promega; anti-PARP and antiphospho-p38 antibodies were from New England Biolabs; antiphospho-ERK, anti-ERK, antiphospho-Akt/PKB(S473) and anti-Akt/PKB antibodies were from Cell Signalling Technology; the anti-a-Actin antibody was from Sigma.
Immunoblotting
Equal amounts of lysates were electrophoresed through 6% polyacrylamide-SDS gels and transferred to polyvinylidene difluoride (PVDF) membranes. Membranes were incubated with primary antibodies at 4 o C overnight, washed and stained with horseradish peroxidase-coupled secondary antibodies. The membranes were developed with an enhanced chemiluminescence kit (Amersham).
Electrophoretic mobility shift assays (EMSAs)
DNA binding assays were carried out as previously described (Li and Shaw, 2002) . Extracts were incubated with a 32 Plabelled oligonucleotide duplex (M67SIE) and protein-DNA complexes swere separated by electrophoresis on 5% polyacrylamide gels containing 2.5% glycerol in 0.5 Â tris-borate-EDTA (TBE) buffer. Gels were fixed, dried and analysed with a phosphorimager (Fuji). For supershift analyses of STAT-DNA complexes, extracts were preincubated with anti-STAT3 antiserum at room temperature for 1 h.
Cell proliferation assays
Equal numbers of cells were seeded in the appropriate growth medium and allowed to grow in the presence of various concentrations of OdDHL, OHHL or other inhibitors, as indicated, for 24 or 48 h. For 48-h time points, fresh medium containing the appropriate inhibitor was applied to the cells after 24 h. Control cells grew for 48 h in the absence of inhibitor. Thereafter, all the cells were washed twice with icecold PBS and counted under a phase-contrast microscope. Values are expressed as averages 7 s.d. (n ¼ 3). Wortmannin, PD98059, SB203580 and Etoposide were from Calbiochem; AG490 was from Sigma. For fluorescent cell counting, MCF-7 cells were cotransfected (Lipofectamine) with pEGFP and either pRc/CMV or pRC/CMV STAT3-C. Thereafter, cells were incubated with or without 50 mM OdDHL for 18 h, harvested and GFP-positive cells were counted under fluorescent microscopy. Values are expressed as averages 7 s.d. (n ¼ 3). For Annexin V binding, trypsinized cells were washed once in Annexin V binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ), incubated for 15 min with Annexin V-APC (Biocarta, CA, USA) in the dark and then analysed for GFP expression and Annexin V-APC binding by flow cytometry (Coulter).
Nucleosomal DNA fragmentation
Total DNA was prepared from 5 Â 10 5 control cells or cells treated overnight with 100 mM OdDHL, as described (McGahon et al., 1995) . DNA was separated by electrophoresis through 1.5% agarose gels in 1 Â TAE buffer, stained with ethidium bromide and photographed under UV light. 
